Biotech and pharmaceutical stocks rose after the election, reflecting investor optimism that a Trump presidency would mean less focus on drug prices. Not so fast, president-elect Trump said in his interview for Time 'Person of the Year.'
Biotech and pharmaceutical stocks rose after the election, reflecting investor optimism that a Trump presidency would mean less focus on drug prices. Not so fast, president-elect Trump said in his interview for Time 'Person of the Year.'